Press release from Companies
Published: 2024-03-01 10:00:00
Redsense Medical CEO Pontus Nobréus will present at the Swiss Nordic Bio in Zürich on March 7, 2024. Swiss Nordic Bio in Zurich is a high-level partnering and investor event where Swiss and Nordic biotech and healthtech startups, pharmaceutical companies and investors meet. Swiss Nordic Bio carries 17 years of tradition, previously Swiss Scandinavian Bio-Business Seminar, and is organised by the Nordic countries in cooperation with Swiss partners. For further information about the event, please visit: swissnordicbio.com Contact information For more information, please contact: Redsense Medical AB (publ), 556646-4862
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com